Tag results:
cell proliferation
Prostate Cell News
Regulatory Mechanism of Androgen Receptor on NCAPD3 Gene Expression in Prostate Cancer
[Prostate] NCAPD3 is an androgen/AR axis-targeted gene and is involved in androgen receptor (AR)-induced prostate cancer (PCa) cell proliferation, migration, and invasion in vitro and in vivo. Androgen treatment and AR overexpression increased the expression of NCAPD3 in PCa cell lines.
Umbilical & Placental Cell News
Small Intestinal Submucosa Membrane Modified by Fusion Peptide-Mediated Extracellular Vesicles to Promote Tissue Regeneration
[Advanced Healthcare Materials] Extracellular vesicles (EVs) derived from umbilical cord MSCs can achieve rapid cell proliferation and migration with little immune response by creating a satisfactory microenvironment. Fusion peptide-mediated EVs were able to modify the surface of the small intestinal submucosa membrane via specific combination.
Hepatic Cell News
Hsa_circ_0011385 Knockdown Represses Cell Proliferation in Hepatocellular Carcinoma
[Cell Death Discovery] High expression of circ_0011385 was observed in hepatocellular carcinoma tissues and cell lines and was significantly associated with tumor size, TNM stage, and prognosis.
Intestinal Cell News
RNF144A-AS1, a TGF-β1- and Hypoxia-Inducible Gene That Promotes Tumor Metastasis and Proliferation via Targeting the miR-30c-2-3p/LOX Axis in Gastric Cancer
[Cell & Bioscience] Scientists explored the function and characterize the underlying mechanism of long noncoding RNA RNF144A-AS1 in gastric cancer metastasis and outgrowth.
Extracellular Matrix News
The Non-Coding RNA Interactome in Joint Health and Disease
[Nature Reviews Rheumatology] Scientists synthesize literature published in the past two years on the role of non-coding RNAs in osteoarthritis and rheumatoid arthritis with a focus on inflammation, cell death, cell proliferation and ECM dysregulation.
Immune Regulation News
BTN2A2 Protein Negatively Regulates T Cells to Ameliorate Collagen-Induced Arthritis in Mice
[Scientific Reports] Researchers investigated the ability of a recombinant BTN2A2-IgG2a Fc fusion protein to treat Collagen type II (CIA). They showed that administration of BTN2A2-Ig attenuatex established CIA, as compared with control Ig protein treatment.